Anzeige
Meldung des Tages: USA erklären Kupfer zur Chefsache – dieser Nevada-Explorer bohrt bereits

Carl Zeiss Meditec Aktie (ADR) News

Aktie
WKN:  A0YGQ7 ISIN:  US14218T1051 US-Symbol:  CZMWY Branche:  Gesundheitswesen: Ausstattung u. Produkte Land:  Deutschland
24,80 €
-1,80 €
-6,77%
08:01:51 Uhr
Depot/Watchlist
Marktkapitalisierung *
3,52 Mrd. €
Streubesitz
100,00%
KGV
23,60
Dividende
0,58 EUR
Dividendenrendite
1,49%
Faktor
1
Originalaktie
DE0005313704

Carl Zeiss Meditec Aktie (ADR) News

02.09.25 - PR Newswire
ZEISS showcases expansion of ophthalmic care options creating industry-leading workflow solutions; marks new refractive and cataract milestones
ZEISS showcases expansion of ophthalmic care options creating industry-​leading workflow solutions; marks new refractive and cataract milestones PR Newswire
02.09.25 - PR Newswire
ZEISS showcases expansion of ophthalmic care options creating industry-leading workflow solutions; marks new refractive and cataract milestones
ZEISS showcases expansion of ophthalmic care options creating industry-​leading workflow solutions; marks new refractive and cataract milestones PR Newswire
26.08.25 - PR Newswire
ZEISS showcases comprehensive workflow for full spectrum of retina care at EURETINA
ZEISS showcases comprehensive workflow for full spectrum of retina care at EURETINA PR Newswire
26.08.25 - PR Newswire
ZEISS showcases comprehensive workflow for full spectrum of retina care at EURETINA
ZEISS showcases comprehensive workflow for full spectrum of retina care at EURETINA PR Newswire
21.08.25 - PR Newswire
ZEISS announces CE mark for CIRRUS PathFinder AI tool with automated OCT assessment
ZEISS announces CE mark for CIRRUS PathFinder AI tool with automated OCT assessment PR Newswire
21.08.25 - PR Newswire
ZEISS announces CE mark for CIRRUS PathFinder AI tool with automated OCT assessment
ZEISS announces CE mark for CIRRUS PathFinder AI tool with automated OCT assessment PR Newswire
05.06.25 - PR Newswire
ZEISS CLARUS 700 Receives NMPA Approval in China
ZEISS CLARUS 700 Receives NMPA Approval in China PR Newswire
05.06.25 - PR Newswire
ZEISS CLARUS 700 Receives NMPA Approval in China
ZEISS CLARUS 700 Receives NMPA Approval in China PR Newswire
30.04.25 - PR Newswire
ZEISS unveils AI-powered Research Data Platform; collaboration with Boehringer Ingelheim champions the future of personalized eye care
ZEISS unveils AI-​powered Research Data Platform; collaboration with Boehringer Ingelheim champions the future of personalized eye care PR Newswire
30.04.25 - PR Newswire
ZEISS unveils AI-powered Research Data Platform; collaboration with Boehringer Ingelheim champions the future of personalized eye care
ZEISS unveils AI-​powered Research Data Platform; collaboration with Boehringer Ingelheim champions the future of personalized eye care PR Newswire
17.04.25 - PR Newswire
ZEISS continues to drive digital era forward in ophthalmology; celebrates 2 million digitally-planned cataract cases in the U.S. alone
ZEISS continues to drive digital era forward in ophthalmology; celebrates 2 million digitally-​planned cataract cases in the U.S. alone PR Newswire
17.04.25 - PR Newswire
ZEISS continues to drive digital era forward in ophthalmology; celebrates 2 million digitally-planned cataract cases in the U.S. alone
ZEISS continues to drive digital era forward in ophthalmology; celebrates 2 million digitally-​planned cataract cases in the U.S. alone PR Newswire
09.04.25 - PR Newswire
ZEISS receives FDA clearance for INTRABEAM 700
ZEISS receives FDA clearance for INTRABEAM 700 PR Newswire
27.03.25 - PR Newswire
ILM-Blue from DORC Receives NMPA Approval in China; Expanding Global Reach
ILM-Blue from DORC Receives NMPA Approval in China; Expanding Global Reach PR Newswire
27.03.25 - PR Newswire
ILM-Blue from DORC Receives NMPA Approval in China; Expanding Global Reach
ILM-Blue from DORC Receives NMPA Approval in China; Expanding Global Reach PR Newswire

Newssuche

Videos

newspaper
04.03.26 +10,01%
ROHÖL mit Ziel MINUS 40$?!?
Fundierte Strategien für den Handel der wichtigen News in einem Seminarpaket, plus transparenter ... Mehr »